Shafa Orthopedic Journal

Published by: Kowsar

Antibiotic Prophylaxis in Periprosthetic Joint Infection (PJI): literature Review and World Consensus (Part Seven)

Javad Parvizi 1 , * , Mohammad Ghazavi 2 and Members of Pre-Op Antibiotics Committee of the Consensus Meeting 3
Authors Information
1 Rothman Institute, Thomas Jefferson University, Philadelphia, PA, USA
2 Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, IR Iran
3 William Arnold MD PhD; Katherine Belden MD; Goran Bicanic; Stefano Bini MD; Fabio Catani MD; Jiying Chen MD PhD; Mohammad Ghazavi MD FRCSC; Karine M Godefroy MD; Erik Hansen MD; Paul Holham MD; Hamid Hosseinzadeh MD; Kang II Kim MD; Klaus Kirketerp-Moller MD; Lars Lidgren MD PhD; Jian Hao Lin MD; Jess H Lonner MD; Christopher Moore MD; Panayiotis Papagelopoulos MD; Lazaros Poultsides MD MSc PhD; Khalid Saleh MD MSC FRCSC MHCM; Julia V Salmon MD, Edward Schwarz PhD; Randi Silibovsky MD (US); Jose Stuyck MD; Markus Vogt MD; (International); Annette W Dahl MD; Koji Yamada MD.
Article information
  • Shafa Orthopedic Journal: August 2016, 3 (3); e7535
  • Published Online: July 12, 2016
  • Article Type: Review Article
  • Received: June 14, 2016
  • Accepted: July 8, 2016
  • DOI: 10.17795/soj-7535

To Cite: Parvizi J, Ghazavi M, Committee of the Consensus Meeting M O P A. Antibiotic Prophylaxis in Periprosthetic Joint Infection (PJI): literature Review and World Consensus (Part Seven), Shafa Ortho J. 2016 ; 3(3):e7535. doi: 10.17795/soj-7535.

Copyright © 2016, Iran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results:
4. Conclusions
  • 1. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998; 27(5): 1247-54[PubMed]
  • 2. Yang K, Yeo SJ, Lee BP, Lo NN. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty. 2001; 16(1): 102-6[DOI][PubMed]
  • 3. Meding JB, Reddleman K, Keating ME, Klay A, Ritter MA, Faris PM, et al. Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res. 2003; (416): 208-16[DOI][PubMed]
  • 4. Pedersen AB, Mehnert F, Johnsen SP, Sorensen HT. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J Bone Joint Surg Br. 2010; 92(7): 929-34[DOI][PubMed]
  • 5. Adams AL, Paxton EW, Wang JQ, Johnson ES, Bayliss EA, Ferrara A, et al. Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am. 2013; 95(6): 481-7[DOI][PubMed]
  • 6. Haverkamp D, Klinkenbijl MN, Somford MP, Albers GH, van der Vis HM. Obesity in total hip arthroplasty--does it really matter? A meta-analysis. Acta Orthop. 2011; 82(4): 417-22[DOI][PubMed]
  • 7. Namba RS, Paxton L, Fithian DC, Stone ML. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty. 2005; 20(7 Suppl 3): 46-50[DOI][PubMed]
  • 8. Dowsey MM\, Choong PF. Early outcomes and complications following joint arthroplasty in obese patients: a review of the published reports. ANZ J Surg. 2008; 78(6): 439-44
  • 9. Parvizi J, Sullivan TA, Pagnano MW, Trousdale RT, Bolander ME. Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure. J Arthroplasty. 2003; 18(3): 259-64[DOI][PubMed]
  • 10. Ragni MV, Crossett LS, Herndon JH. Postoperative infection following orthopaedic surgery in human immunodeficiency virus-infected hemophiliacs with CD4 counts < or = 200/mm3. J Arthroplasty. 1995; 10(6): 716-21[PubMed]
  • 11. Habermann B, Eberhardt C, Kurth AA. Total joint replacement in HIV positive patients. J Infect. 2008; 57(1): 41-6[DOI][PubMed]
  • 12. Wang TI, Chen CF, Chen WM, Chiang CC, Huang CK, Liu CL, et al. Joint replacement in human immunodeficiency virus-infected patients. J Chin Med Assoc. 2012; 75(11): 595-9[DOI][PubMed]
  • 13. Unger AS, Kessler CM, Lewis RJ. Total knee arthroplasty in human immunodeficiency virus-infected hemophiliacs. J Arthroplasty. 1995; 10(4): 448-52[PubMed]
  • 14. Silva M, Luck JJ. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am. 2005; 87(1): 85-91[DOI][PubMed]
  • 15. Rodriguez-Merchan EC. Total knee replacement in haemophilic arthropathy. J Bone Joint Surg Br. 2007; 89(2): 186-8[DOI][PubMed]
  • 16. Shaarani SR, Collins D, O'Byrne JM. The need for guidelines in asplenic patients undergoing total joint arthroplasty: a case report. Case Rep Orthop. 2012; 2012: 147042[DOI][PubMed]
  • 17. McCleery MA, Leach WJ, Norwood T. Rates of infection and revision in patients with renal disease undergoing total knee replacement in Scotland. J Bone Joint Surg Br. 2010; 92(11): 1535-9[DOI][PubMed]
  • 18. Lieberman JR, Fuchs MD, Haas SB, Garvin KL, Goldstock L, Gupta R, et al. Hip arthroplasty in patients with chronic renal failure. J Arthroplasty. 1995; 10(2): 191-5[PubMed]
  • 19. Sakalkale DP, Hozack WJ, Rothman RH. Total hip arthroplasty in patients on long-term renal dialysis. J Arthroplasty. 1999; 14(5): 571-5[PubMed]
  • 20. Li WC, Shih CH, Ueng SW, Shih HN, Lee MS, Hsieh PH. Uncemented total hip arthroplasty in chronic hemodialysis patients. Acta Orthop. 2010; 81(2): 178-82[DOI][PubMed]
  • 21. Nagoya S, Nagao M, Takada J, Kuwabara H, Kaya M, Yamashita T. Efficacy of cementless total hip arthroplasty in patients on long-term hemodialysis. J Arthroplasty. 2005; 20(1): 66-71[DOI][PubMed]
  • 22. Pour AE, Matar WY, Jafari SM, Purtill JJ, Austin MS, Parvizi J. Total joint arthroplasty in patients with hepatitis C. J Bone Joint Surg Am. 2011; 93(15): 1448-54[DOI][PubMed]
  • 23. Orozco F, Post ZD, Baxi O, Miller A, Ong A. Fibrosis in hepatitis C patients predicts complications after elective total joint arthroplasty. J Arthroplasty. 2014; 29(1): 7-10[DOI][PubMed]
  • 24. Vergidis P, Lesnick TG, Kremers WK, Razonable RR. Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study. Transpl Infect Dis. 2012; 14(4): 380-6[DOI][PubMed]
  • 25. Tannenbaum DA, Matthews LS, Grady-Benson JC. Infection around joint replacements in patients who have a renal or liver transplantation. J Bone Joint Surg Am. 1997; 79(1): 36-43[PubMed]
  • 26. Mortazavi SM, Molligan J, Austin MS, Purtill JJ, Hozack WJ, Parvizi J. Failure following revision total knee arthroplasty: infection is the major cause. Int Orthop. 2011; 35(8): 1157-64[DOI][PubMed]
  • 27. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res. 1984; (182): 117-26[PubMed]
  • 28. Sierra RJ, Cooney W, Pagnano MW, Trousdale RT, Rand JA. Reoperations after 3200 revision TKAs: rates, etiology, and lessons learned. Clin Orthop Relat Res. 2004; (425): 200-6[PubMed]
  • 29. Bal BS, Brenner LH. Corporate malfeasance, off-label use, and surgeon liability. Clin Orthop Relat Res. 2013; 471(1): 4-8[DOI][PubMed]
  • 30. Thakuria B, Singh P, Agrawal S, Asthana V. Profile of infective microorganisms causing ventilator-associated pneumonia: A clinical study from resource limited intensive care unit. J Anaesthesiol Clin Pharmacol. 2013; 29(3): 361-6[DOI][PubMed]
  • 31. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007; 20(3): 440-58[DOI][PubMed]
  • 32. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA. 2008; 300(24): 2911-3[DOI][PubMed]
  • 33. Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005; 165(12): 1430-5[DOI][PubMed]
  • 34. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother. 2008; 52(4): 1413-8[DOI][PubMed]
  • 35. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother. 2008; 52(2): 796-7[DOI][PubMed]
  • 36. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009; 360(1): 20-31[DOI][PubMed]
  • 37. Perez F, Pultz MJ, Endimiani A, Bonomo RA, Donskey CJ. Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother. 2011; 55(6): 2585-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments